NAD+ and Resveratrol: Do They Actually Work Together?

Written by the Nuvirox Research Team | Sources cited below | Updated June 2026

Short answer: NAD+ and resveratrol have a genuine mechanistic reason to be paired, but the human evidence that the combination delivers real benefits is thin — and in at least one case, resveratrol worked against the goal. The rationale is elegant: NAD+ powers sirtuin enzymes, and resveratrol is a sirtuin activator, so combining a precursor (to raise NAD+) with resveratrol (to nudge the enzymes) looks like a one-two punch on paper. The honest caveat is that resveratrol has been one of the most over-promised molecules in supplement history, with shaky bioavailability and mixed clinical results. The pairing is plausible, not proven.

Why are NAD+ and resveratrol linked at all?

The connection runs through sirtuins. Sirtuins are a family of seven enzymes (SIRT1–7) that help regulate metabolism, DNA repair, and stress responses — and crucially, they can't work without NAD+, which they consume as a co-substrate. When NAD+ is abundant, sirtuins have the fuel to operate; when it's scarce, they idle. That's the first half of the story, and it's why raising NAD+ is interesting in the first place.

Resveratrol entered the picture about two decades ago when it was reported to activate SIRT1, mimicking some effects of calorie restriction. So the combination logic became: use an NAD+ precursor to top up the substrate, and use resveratrol to activate the enzyme that uses it. If you've read our explainer on NAD+ precursors, this is the natural next question — once you've raised NAD+, can you make your cells do more with it?

Does resveratrol really activate sirtuins?

Here's where the story gets honest. Resveratrol does activate SIRT1 in the lab — but the mechanism turned out to be more complicated than the early headlines. Detailed studies showed that resveratrol's activation is substrate-specific: it depends partly on the chemical "tag" attached to the test molecule, which sparked years of debate about how much of the original lab signal reflects real biology versus an artifact of the assay (Hou et al., 2016). The current understanding is that resveratrol can stabilize SIRT1's interaction with certain substrates — a real effect, but a subtler and more conditional one than "resveratrol switches on your longevity genes."

What's the catch with resveratrol itself?

Bioavailability. Resveratrol is absorbed and then cleared from the body rapidly, so very little circulating, active resveratrol reaches your tissues from an oral dose. This is the central reason its impressive lab and animal data have been so hard to reproduce in people, and it's why many formulations use better-absorbed relatives such as pterostilbene (a methylated cousin of resveratrol found in blueberries). The molecule that looks unstoppable in a petri dish has a hard time even showing up in human blood at meaningful levels.

What do human trials of the combination show?

The closest direct evidence comes from NAD+ precursor + polyphenol combinations. A randomized, placebo-controlled trial of 120 adults aged 60–80 tested NR combined with pterostilbene. The combination raised whole-blood NAD+ by roughly 40% at the recommended dose and about 90% at double dose, sustained over 8 weeks, with no serious adverse events (Dellinger et al., 2017). That establishes the combination is safe and that the NAD+-raising effect (driven by the precursor) holds up alongside a polyphenol. What it does not establish is that adding the polyphenol produces benefits beyond what the precursor alone would.

And the counterweight that the marketing skips. Resveratrol doesn't always help — sometimes it interferes. In a controlled trial, 27 inactive older men did 8 weeks of exercise training while taking either 250 mg/day of trans-resveratrol or placebo. Exercise improved cardiovascular markers in the placebo group, but resveratrol blunted those gains, including the improvement in aerobic capacity (Gliemann et al., 2013). The likely explanation is that exercise benefits depend partly on transient oxidative stress, and resveratrol's antioxidant action dampened that signal. It's a vivid reminder that "more antioxidant activation" is not automatically better, and that resveratrol's effects in humans are context-dependent.

What the pairing won't do (and when to check with a doctor)

Combining NAD+ precursors with resveratrol won't reverse aging, and there's no human trial showing that the pair outperforms a precursor alone on any meaningful health outcome. The honest summary: the biochemistry is reasonable, the safety of precursor-plus-polyphenol combinations looks acceptable, and the proof of added benefit is missing. If you're drawn to the combination for a specific health reason, that reason deserves a medical conversation rather than a supplement bet — particularly because resveratrol can interact with medications (it can affect how some drugs are metabolized and may influence bleeding risk). Talk to your doctor before combining it with prescriptions, if you're pregnant or breastfeeding, or before a planned surgery.

How is the combination typically dosed?

In the formulations with human data, the NAD+ precursor carries the NAD+-raising load at trial-range doses (roughly hundreds of milligrams per day), while the polyphenol is included at much smaller amounts — the combination trial above used pterostilbene in the tens of milligrams (Dellinger et al., 2017). Notably, the resveratrol exercise study used a substantial 250 mg/day dose and still produced an unwanted effect, which argues against assuming "more resveratrol is better." As with precursors alone, NAD+ shifts unfold over about two weeks, so any reasonable evaluation is measured in weeks.

Frequently asked questions

Should I take resveratrol with my NAD+ supplement?
There's a sound mechanistic rationale, and combinations have been shown safe, but no human trial proves the pair beats a precursor alone. It's a reasonable addition, not a proven upgrade.

Is pterostilbene better than resveratrol?
It's better absorbed, which is why many NAD+ formulations use it. Better absorption doesn't automatically mean better outcomes, but it addresses resveratrol's biggest practical weakness.

Could resveratrol cancel out my workouts?
One trial found high-dose resveratrol blunted exercise-induced cardiovascular gains in older men. The finding is debated, but it's a real reason not to megadose around training.

Does resveratrol raise NAD+ on its own?
No — resveratrol acts on the enzymes that use NAD+, not on NAD+ production. To raise NAD+ itself, you need a precursor; see NR vs. NMN vs. NAD+.

How do I choose a product that combines them well?
Focus on the precursor's dose and quality first; treat the polyphenol as a bonus, not the headline. Our buyer's guide walks through it, and side effects covers safety of stacking.

The bottom line

NAD+ and resveratrol are paired for a real reason: NAD+ fuels sirtuins, and resveratrol can act on them. But the human evidence lags well behind the elegant theory. Resveratrol's lab activation is more conditional than advertised, its absorption is poor, and it has occasionally worked against the goal — as the exercise trial showed. The strongest claim the data support is modest: NAD+ precursor + polyphenol combinations raise NAD+ safely. Anything beyond that is, for now, a reasonable hypothesis rather than a settled benefit.

References

1. Dellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis. 2017;3:17. DOI: 10.1038/s41514-017-0016-9. PMID: 29184669.
2. Gliemann L, Schmidt JF, Olesen J, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol. 2013;591(20):5047–5059. DOI: 10.1113/jphysiol.2013.258061. PMID: 23878368.
3. Hou X, Rooklin D, Fang H, et al. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation. Sci Rep. 2016;6:38186. DOI: 10.1038/srep38186.
4. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. DOI: 10.1038/s41598-019-46120-z. PMCID: PMC6611812.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.